Komori
Kidswell Bio (4584) · RiskRestated

Risk that new development products will not be discovered or created

First written in FY2017. 7 of 8 entries say "Restated". Latest entry: FY2023-Q3.

8entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY2023-Q32017: 220172018: 320182019: 120192020: 120202021: 020212022: 020222023: 1
Same theme, other companies
Uncertainty in Discovering and Creating New Drug PipelinesA theme 5 companies write about · 5 as a headwind · 0 as a tailwind

2 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3RestatedAnnual report

    「During the cumulative third-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」

    The company has disclosed that there have been no material changes in the risk that new products under development cannot be identified or created.
  2. FY2020RestatedAnnual report

    「However, these activities do not guarantee that new products under development can be identified and created.」

    The company continues to disclose the risk that new products under development cannot be identified or created through partnerships.
  3. FY2019RestatedAnnual report

    「However, these activities do not guarantee that new products under development can be identified and created.」

    The company continues to disclose the risk that new products under development cannot be identified or created through partnerships.
  4. FY2019-Q1RestatedAnnual report

    「During the cumulative first-quarter period, there were no new business or other risks and no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company has disclosed that there have been no material changes in the risk that new products under development cannot be identified or created.
  5. FY2018RestatedAnnual report

    「The company considers the active development of partnerships outside the company to identify and create new products under development an important business strategy. However, these activities do not guarantee that new products under development can be identified and created.」

    The company continues to disclose the risk that new products under development cannot be identified or created through partnerships.
  6. FY2018-Q3RestatedAnnual report

    「During the nine months ended September, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」

    The company has disclosed that there have been no material changes in the risk that new products under development cannot be identified or created.
  7. FY2018-Q2RestatedAnnual report

    「During the six months ended June, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」

    The company has disclosed that there have been no material changes in the risk that new products under development cannot be identified or created.
  8. FY2017First statedAnnual report

    「The company considers the active development of partnerships outside the company to identify and create new products under development an important business strategy. However, these activities do not guarantee that new products under development can be identified and created.」

    The company has for the first time disclosed as an independent research and development risk that identifying and creating new products under development through partnerships is not guaranteed.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kidswell Bio yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk that new development products will not be discovered or created | Kidswell Bio Corporation (4584) | Komori